3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
64
Head and Neck Neoplasms
63
Squamous Cell Carcinoma of Head and Neck
60
Carcinoma, Non-Small-Cell Lung
34
Rectal Neoplasms
23
Colonic Neoplasms
23
Neoplasm Metastasis
19
Neoplasms
18
Carcinoma, Squamous Cell
17
Pancreatic Neoplasms
13
Lung Neoplasms
13
Esophageal Neoplasms
11
Tongue Neoplasms
9
Stomach Neoplasms
9
Recurrence
9
Carcinoma
8
Neoplasms, Squamous Cell
6
Mouth Neoplasms
6
Laryngeal Neoplasms
6
Breast Neoplasms
6
Adenocarcinoma Of Esophagus
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Esophageal Squamous Cell Carcinoma
5
Adenocarcinoma of Lung
5
Sarcoma
4
Salivary Gland Neoplasms
4
Oropharyngeal Neoplasms
4
Laryngeal Diseases
4
Precancerous Conditions
3
Hypopharyngeal Neoplasms
3
Interventions
Rituximab
4
blinatumomab
3
Whole-Body Irradiation
3
Cyclophosphamide
3
fludarabine phosphate
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Clofarabine
2
treosulfan
1
thymoglobulin
1
sabatolimab
1
pembrolizumab
1
peginterferon alfa-2a
1
obinutuzumab
1
midostaurin
1
ixazomib
1
fludarabine
1
eribulin
1
daratumumab
1
acalabrutinib
1
Trastuzumab
1
Tacrolimus
1
Sodium Chloride
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Pentostatin
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Methotrexate
1
Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasm, Residual
×
Cetuximab
×
Clear all
No trials found.